Delivery Order SPE2DE21D0005-SPE2D625F31DY
Award Date
1/16/25
Potential Completion Date
1/22/25
Potential Value
$1.2K
Federal Agency
Medical Supply Chain
Awardee
Organogenesis Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price contract with economic price adjustment is for the delivery of APLIGRAF, a skin substitute product. Organogenesis, a for-profit manufacturer, has an established track record of supplying specialized medical supplies, including wound care and tissue regeneration solutions, to the...
This federal contract award is for a delivery order (SPE2DE21D0005|SPE2D625F52FT) with a ceiling value of $1,239.95, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit medical manufacturer headquartered in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order, valued at $1,239.95, is for the company's APLIGRAF skin substitute product. The order is a fixed-price contract with economic price adjustment, and does not utilize a set-aside designation. Organogenesis Inc. is a long-standing federal contractor, providing a range of wound care and surgical biologics to the...
This federal contract award, with ID SPE2DE21D0005|SPE2D625F83GA, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer and provider of regenerative medical products. The $1,239.95 fixed-price delivery order contract is for the supply of APLIGRAF, a skin substitute product, to support advanced wound care and tissue regeneration needs across military and veteran healthcare systems. Organogenesis holds several significant federal Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,239.95 Delivery Order (SPE2DE21D0005|SPE2D625F228P) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is for the delivery of the advanced wound care product APLIGRAF. The order is a Fixed Price with Economic Price Adjustment contract with a completion date of November 1, 2024. Organogenesis, headquartered in Canton, Massachusetts, is a key supplier of medical products to federal...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth $49.5 million, for wound care dressings and medical supplies. Organogenesis, headquartered in Canton, Massachusetts, specializes in advanced wound care, surgical biologics, and tissue...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,479.90 Delivery Order contract to Organogenesis Inc., a leading regenerative medicine company, to provide APLIGRAF, a specialized skin substitute and wound matrix product. The contract has a period of performance through November 25, 2024 and utilizes a Fixed Price with Economic Price Adjustment pricing structure. Organogenesis is a for-profit manufacturer that has been awarded numerous federal contracts to supply a range...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for APLIGRAF, a skin substitute product. The contract has no set-aside designation, indicating Organogenesis competed as a standard commercial vendor. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 firm-fixed-price delivery order, awarded on December 18, 2024, is for the supply of APLIGRAF, a regenerative skin substitute product. The award is not associated with a set-aside program and is part of Organogenesis' broader...
This is a federal delivery order contract awarded to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract, valued at $1,239.95, is for the supply of APLIGRAF, a specialized skin substitute product used in advanced wound care treatments. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and does not utilize any set-aside designations. Organogenesis has been a consistent supplier of wound care and...